Portfolio company
Orikine Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
Deep Tech
About
This company develops engineered cytokine therapies for patients with autoimmune and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.